UCSD Researchers Find Potential Cure for Brain Amoeba
A marine-derived compound shows promise in rapidly neutralizing a deadly brain-eating parasite.
Updated on Oct. 26, 2026 in Diseases — General
Live Poll
Should the government prioritize funding for marine-based research to develop treatments for rare, deadly diseases?
University of California San Diego researchers have identified a compound called rutamycin B that shows high efficacy against Naegleria fowleri. This discovery could offer a faster, more targeted treatment for primary amoebic meningoencephalitis.
Why it matters
Current medical treatments for this infection are often too slow to act and carry high levels of toxicity for patients. This new compound provides a more potent alternative that may reduce the reliance on harsh, existing drugs.
Rutamycin B reaches full potency against the parasite in four hours, significantly faster than the 16 hours required by the standard treatment, amphotericin B. The compound is 200 to 300 times more lethal to the parasite than to human cells.
The players
University of California San Diego
This public research university serves as a major hub for scientific innovation and biomedical advancement.
The details
Isolated from a marine bacterium, the compound functions by inhibiting an enzyme that the parasite requires for energy production. It can be used in combination therapies at just 3% to 10% of the original dose, potentially lowering toxicity risks.
Timeline
October 26, 2026: Researchers published their findings on the rutamycin B compound.
Health Landscape
This discovery marks a significant expansion of the University of California San Diego's marine drug discovery program into the field of parasitic treatment. The research extends the capabilities of the institution by identifying new medical applications for marine-derived compounds.
This development could eventually lead to faster intervention options for patients facing primary amoebic meningoencephalitis. Future studies will determine if this treatment can be safely and effectively administered to combat the disease in human cases.
The takeaway
This breakthrough highlights the untapped potential of marine bacteria in developing life-saving medical treatments. Identifying compounds that target parasitic energy systems offers a promising new pathway to address infections with high mortality rates.
Further reading
Learn more about new developments in medical research at the San Diego Diseases — General page.
More information
Review the full findings in the scientific study in Marine Drugs.
Live Poll
Should the government prioritize funding for marine-based research to develop treatments for rare, deadly diseases?
